NASDAQ:NDRA

ENDRA Life Sciences (NDRA) Stock Price, News & Analysis

$0.25
0.00 (0.00%)
(As of 04/22/2024 ET)
Today's Range
$0.25
$0.25
50-Day Range
$0.23
$1.21
52-Week Range
$0.22
$2.79
Volume
18,144 shs
Average Volume
167,838 shs
Market Capitalization
$2.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NDRA stock logo

About ENDRA Life Sciences Stock (NASDAQ:NDRA)

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

NDRA Stock Price History

NDRA Stock News Headlines

[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
Q4 2023 ENDRA Life Sciences Inc Earnings Call
Earnings Preview For ENDRA Life Sciences
[Shocking] Elon Musk’s Plan To End Banks
Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030.
ENDRA Life Sciences Installs First TAEUS System in the UK
ENDRA Life Sciences Installs First TAEUS System in the UK
ENDRA Life Sciences Inc (NDRA)
ENDRA Life Sciences Inc.
See More Headlines
Receive NDRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
4/22/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NDRA
Fax
N/A
Employees
21
Year Founded
N/A

Profitability

Net Income
$-10,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.67 per share

Miscellaneous

Free Float
10,506,000
Market Cap
$2.76 million
Optionable
Not Optionable
Beta
0.98
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Francois Michelon (Age 58)
    Chairman, President & CEO
    Comp: $423.59k
  • Mr. Michael Thornton Ph.D. (Age 56)
    Chief Technology Officer
    Comp: $301.67k
  • Dr. Jonathan Behr Ph.D.
    Co-Founder
  • Ms. Irina Pestrikova (Age 37)
    Senior Director of Finance & Secretary
  • Mr. Steve Freeman
    Human Resources Leader

NDRA Stock Analysis - Frequently Asked Questions

How have NDRA shares performed in 2024?

ENDRA Life Sciences' stock was trading at $2.12 at the beginning of 2024. Since then, NDRA shares have decreased by 88.2% and is now trading at $0.2502.
View the best growth stocks for 2024 here
.

Are investors shorting ENDRA Life Sciences?

ENDRA Life Sciences saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 30,600 shares, a decline of 36.9% from the March 15th total of 48,500 shares. Based on an average daily volume of 170,700 shares, the short-interest ratio is presently 0.2 days. Currently, 0.3% of the company's shares are short sold.
View ENDRA Life Sciences' Short Interest
.

When is ENDRA Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NDRA earnings forecast
.

How were ENDRA Life Sciences' earnings last quarter?

ENDRA Life Sciences Inc. (NASDAQ:NDRA) posted its quarterly earnings data on Thursday, March, 28th. The company reported ($0.17) earnings per share for the quarter.

What other stocks do shareholders of ENDRA Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), electroCore (ECOR) and Genocea Biosciences (GNCA).

When did ENDRA Life Sciences IPO?

ENDRA Life Sciences (NDRA) raised $10 million in an IPO on Friday, February 3rd 2017. The company issued 2,000,000 shares at a price of $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO.

How do I buy shares of ENDRA Life Sciences?

Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NDRA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners